IDiyas

For the Inventor, By the Inventor

Delmar, NY, United States of America

Pavel E Zhichkin

USPTO Granted Patents = 14


 

Average Co-Inventor Count = 10.0

ph-index = 5

Forward Citations = 93(Granted Patents)


Location History:

  • Albany, NY (US) (2003)
  • Latham, NY (US) (2005 - 2012)
  • Delmar, NY (US) (2011 - 2019)

Company Filing History:

goldMedal7 out of 30 
 
Gilead Connecticut, Inc.
 patents
silverMedal5 out of 3,221 
 
Genentech, Inc.
 patents
bronzeMedal3 out of 13 
 
Cgi Pharmaceuticals, Inc.
 patents
4. 3 out of 37 
 
Telik, Inc.
 patents
5. 1 out of 164 
 
Icos Corporation
 patents
6. 1 out of 1 
 
Deltagen Research Labs, LLC
 patent
7. 1 out of 98 
 
Genetech, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2003-2019

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):
1. 10344040 - Pyridone and aza-pyridone compounds and methods of use (2019-07-09),
2. 10053469 - Pyridone and aza-pyridone compounds and methods of use (2018-08-21),
3. 9505785 - Pyridone and aza-pyridone compounds and methods of use (2016-11-29),
4. 8618107 - Pyridone and aza-pyridone compounds and methods of use (2013-12-31),
5. 8598174 - Pyridazinones, method of making, and method of use thereof (2013-12-03),
6. 8426424 - Certain substituted amides, method of making, and method of use thereof (2013-04-23),
7. 8334266 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-12-18),
8. 8247550 - Certain substituted amides, method of making, and method of use thereof (2012-08-21),
9. 8222421 - Certain substituted ureas, as modulators of kinase activity (2012-07-17),
10. 8198247 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-06-12),
11. 7884108 - Certain substituted pyrazinones (2011-02-08),
12. 7777040 - Certain substituted ureas, as modulators of kinase activity (2010-08-17),
13. 6924284 - PARP inhibitors (2005-08-02),
14. 6506739 - Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents (2003-01-14),

Title: The Innovations of Pavel E Zhichkin

Introduction

Pavel E Zhichkin is a notable inventor based in Delmar, NY (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the development of compounds that target immune disorders.

Latest Patents

Zhichkin's latest patents focus on pyridone and aza-pyridone compounds, which are designed to inhibit Btk kinase. These compounds, including their stereoisomers, tautomers, and pharmaceutically acceptable salts, are particularly useful for treating immune disorders such as inflammation mediated by Btk kinase. The patents also disclose methods for using these compounds in vitro, in situ, and in vivo for the diagnosis and treatment of related pathological conditions in mammalian cells.

Career Highlights

Throughout his career, Zhichkin has worked with prominent companies in the pharmaceutical industry, including Gilead Connecticut, Inc. and Genentech, Inc. His work has contributed to the advancement of medical treatments and has had a positive impact on patient care.

Collaborations

Zhichkin has collaborated with esteemed colleagues such as Peter A Blomgren and Scott A Mitchell, further enhancing the innovative work being done in his field.

Conclusion

Pavel E Zhichkin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the treatment of immune disorders, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…